Clinical trial

Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis

NCT05072691

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2020-07-14

PhaseN/A

Study timeline

Study start (actual)2020-07-14Date precision: day

Registry last updated2025-10-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

CSF immunoglobulin (Ig) free light chains (FLC) dosageDIAGNOSTIC_TEST

Sponsors & collaborators

Francis Corazzalead sponsor

Mapped research locations

BrusselsBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05072691 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.